nach oben

Erschienen in:

01.06.2019 | Case report

Tofacitinib

Hypercalcaemia and increased body weight: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a study, two women aged 54 years and 55 years were described, of whom, one woman developed hypercalcaemia with increased body weight and another woman developed increased body weight during treatment with tofacitinib for calcifications [routes and duration of treatment to reactions onsets not stated; not all outcomes stated]. …

Wendel S, et al. Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases. Journal of Autoimmunity 100: 131-136, Jun 2019. Available from: URL: http://doi.org/10.1016/j.jaut.2019.03.003 - GermanyCrossRefPubMed

Titel: Tofacitinib
Hypercalcaemia and increased body weight: 2 case reports
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63879-x

Springer Medizin

Tofacitinib

Hypercalcaemia and increased body weight: 2 case reports

Excerpt

Weitere Artikel der Ausgabe 1/2019

Ibuprofen

Pasireotide

Vemurafenib

Somatrogon

Rubella-virus-vaccine-live

Sorafenib

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Ibuprofen

Pasireotide

Vemurafenib

Somatrogon

Rubella-virus-vaccine-live

Sorafenib